Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORE1001 in Ulcerative Colitis
NCT01039597Phase 2Unknown
- Sponsor
- Ore Pharmaceuticals
- Start
- Dec 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ORE1001 in ulcerative colitis (UC), sponsored by Ore Pharmaceuticals. Status: unknown.
02
Drugs
ORE1001
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01039597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01039597.